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Abstract The dynamics of the C-terminus of the dUTPases
from Escherichia coli and equine infectious anaemia virus
(EIAV) were studied by 1H^15N nuclear magnetic resonance
spectroscopy. The two enzymes differ with regard to flexibility in
the backbone of the 15 most C-terminal amino acid residues,
some of which are conserved and essential for enzymic activity.
In the bacterial enzyme, the residues closest to the C-terminus
are highly flexible and display a correlation time in the
nanosecond time range. No similar high flexibility could be
detected for the C-terminal part of EIAV dUTPase, indicating a
different time range of flexibility. ß 2001 Federation of Euro-
pean Biochemical Societies. Published by Elsevier Science B.V.
All rights reserved.
Key words: dUTPase; Equine infectious anemia virus;
Flexible C-terminus; Nuclear magnetic resonance;
Nucleotide binding; Escherichia coli
1. Introduction
dUTPase is a ubiquitous enzyme catalysing the hydrolysis
of the nucleotide dUTP to dUMP and inorganic pyrophos-
phate. The reaction is part of the biosynthetic pathway to-
wards dTTP, and is crucial for maintaining the minimal ratio
of dUTP to dTTP essential for the integrity of DNA. Being
expressed in dividing cells [1] and indispensable for viability
[2,3], dUTPase has been suggested as a target for drugs
against cancer [4], as well as against viruses [5] that depend
on a dUTPase of their own [6,7].
Structurally, the dUTPases can be classi¢ed into a few
groups, the major one being represented by the homotrimeric
dUTPases. These globular proteins are in the 50 kDa molec-
ular mass range [8^10] and are similar with respect to enzymic
properties, with high substrate speci¢city and low KM for
dUTP [11^13]. Several crystal structures have been obtained
[14^17]. The discrimination against other pyrimidine nucleo-
tides could be attributed to a hydrophobic pocket, the form
and hydrogen bond characteristics of which being comple-
mentary to the deoxyuridine moiety of the substrate. In the
majority of X-ray structures, a C-terminal portion of about 16
residues is not visible. This part of the protein, here referred
to as the arm, is essential for enzymic activity [18^20]. It
contains a conserved sequence reminiscent of a common motif
with phosphate binding function [21]. A thorough character-
isation of this C-terminal arm is a prerequisite for the assess-
ment of the catalytic mechanism of dUTPase.
So far, the C-terminal arm has been characterised to a
limited extent only. Measurements of the catalytic activity
have been carried out on enzyme with the arm removed
[18,20] or perturbed by alteration of individual amino acid
residues [16,19]. The C-terminal arm of equine infectious
anaemia virus (EIAV) dUTPase was shown to contribute sig-
ni¢cantly to neither the binding strength nor the association
rate constant of the substrate, as monitored by stopped-£ow
£uorescence spectroscopy [20]. Measurements of properties of
the C-terminal arm itself are, however, limited to an investi-
gation by circular dichroism (CD) [22] and to a crystallo-
graphic study of an N-terminally truncated human dUTPase
from which the co-ordinates have not been deposited [16]. The
former study revealed a shift in CD upon binding of nucleo-
tide to the Escherichia coli dUTPase, which was ascribed to
the arm.
To characterise the C-terminus further, we have utilised
nuclear magnetic resonance (NMR) to monitor the dynamics
of the arm. The investigation comprises the dUTPases from
E. coli and EIAV.
2. Materials and methods
2.1. Chemicals and enzyme preparations
Chemicals were of pro analysi quality (Merck, Sigma and Pharma-
cia). dUTP was puri¢ed, and 2P-deoxyuridine-5P-(K,L-imido)triphos-
phate (dUPNPP) [23] was checked for purity, by use of ion exchange
chromatography [12]. Unlabelled recombinant E. coli and EIAV
dUTPases were produced and puri¢ed as before [8,24]. E. coli dUTP-
ase preparations were dialysed extensively against 81 mM sodium
phosphate, 0.006% NaN3, pH 6.0, and concentrated by use of cen-
trifugal concentrators (Macrosep and Microsep, Pall Filtron) to a
concentration of above 1 mM active sites. To test that the protein
preparations would be stable during the NMR measurements, small
samples were stored at 37‡C for 36 h, after which their enzymic
activity was assayed. Enzyme labelled with 15N was prepared as
above, except that the expression strain was grown at 25‡C in M9
minimal medium [25], containing also 15NH4Cl (Martek, MD, USA),
0.1 mM CaCl2 and 20 WM FeCl3, and harvested 8 h post induction.
The EIAV enzyme was treated identically except that dialysis was
done with 60 mM sodium phosphate, pH 6.7, and 0.01% detergent
(C12E8, monodisperse, Nikko Chemicals, Japan), or 8 mM sodium
phosphate and 2 mM MgCl2, pH 6.7, without detergent. This latter
condition for the EIAV dUTPase preparation was selected by activity
assay as the best out of several conditions with di¡erent magnesium
chloride and sodium phosphate concentrations. No antibacterial agent
was added to the preparations of EIAV dUTPase. Instead, the protein
solutions were sterile ¢ltered, and enzymic activity was assayed after
the recording of NMR spectra.
2.2. Assays of protein and enzyme activity
Protein concentration was determined spectroscopically at 280 nm
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using molar extinction coe⁄cients for EIAV and E. coli dUTPase of
15 300 [8] and 8500 M31 cm31, respectively (for the monomers, i.e.
active sites). In order to check for full activity of the enzyme prepa-
rations as well as to con¢rm the determinations of enzyme concen-
tration, the rate of enzymic hydrolysis of 60 WM dUTP was monitored
spectrophotometrically by following the pH dependent shift of cresol
red in a weakly bu¡ered solution of pH 8 [12]. The concentration of
enzyme active sites was estimated from kcat [12,13] and Vmax.
2.3. NMR spectroscopy
The NMR samples contained protein, 0.8^1.3 mM active sites, in
H2O/D2O (90/10) and a phosphate bu¡er (refer to Section 2.1 for
concentrations). Solutions of 280 Wl up to 320 Wl were used in 5 mm
Shigemi NMR tubes. The sensitivity enhanced gradient selected 1H^
15N heteronuclear singular quantum coherence spectroscopy (HSQC)
and 1H^15N total correlation spectroscopy (TOCSY)^HSQC [26]
NMR spectra were recorded at 37‡C on a Varian Unity Inova 600
with a proton frequency of 599.96 MHz, and a TOCSY spectrum on a
GE Omega 500 spectrometer working at a proton resonance fre-
quency of 500.10 MHz. The titrations with either dUDP (74 mM)
or dUPNPP were performed, after addition of MgCl2 to a concen-
tration of 5 mM, by adding Wl amounts of the solutions directly into
the NMR tube by means of a thin plastic tube ¢tted to the tip of a
Finnpipette. In this way, not removing the sample from the NMR
tube, it was possible to perform the titration without any loss of
sample.
3. Results and discussion
In most of the crystal structures for dUTPases reported
[9,14,15,17], a C-terminal part of the polypeptide appears as
unordered. It has frequently been suggested to be £exible
[18,19,22,27], although the only experimental indication of
£exibility is an observation of speci¢c susceptibility towards
tryptic digestion [22]. None, however, of the methods used so
far to study the arm measures £exibility or rates of movement.
Arguing that the C-terminal arm, as essential for catalytic
activity, deserves more investigation, we utilised the NMR
technique to study the rate of movement of the arm. Because
the size of dUTPase gives rise to signi¢cant line broadening in
NMR, signals from £exible parts of the protein should be
distinguishable from signals originating from its rigid body.
Fig. 1A,B show a 1H^15N HSQC NMR spectrum of E. coli
dUTPase. It is obvious that most of the resonances of this
spectrum are broad as expected for a molecule with a molec-
ular mass of 49 kDa. It is, however, also clear that there are,
in addition to some sharp signals from side chain amide
groups, a few resonances that are signi¢cantly sharper than
others (Fig. 1B). Even though we have not made sequence
speci¢c assignments, it is clear from a HSQC^TOCSY spec-
trum (Fig. 1C) that the sharp resonances correspond to amino
acid residues closely matching those of the C-terminal arm of
the protein (see the legend to Fig. 1C). This ¢nding shows that
15 amino acid residues of the C-terminus are £exible. The
correlation time of the residues at, or close to, the C-terminal
end is estimated to be less than 1 ns. The £exibility of the 15
C-terminal residues observed here agrees with the ¢nding that
these residues do not give rise to any interpretable electron
density in crystallography [9,14,15,17]. In an attempt to assess
the sequence of the amino acid residues giving rise to the
strong peaks, a nuclear Overhauser enhancement spectrum
with a mixing time of 200 ms was recorded. It did not, how-
ever, provide any useful information. This is mainly due to the
fact that the broad peaks contribute strongly to the spectrum.
Addition of Mg2, cofactor in the catalysed reaction, has
very little e¡ect on the NMR spectrum. In fact, nothing in our
Fig. 1. A 1H^15N HSQC spectrum of E. coli dUTPase (1 mM active sites). An important point of (A) and (B) is to show that some of the res-
onances of the spectrum are clearly stronger than the majority of the peaks. The former have amplitudes well above the highest amplitude con-
tour of the spectrum as shown here (they appear with a white interior). The di¡erence in amplitude is even clearer in (B), in which the same
spectrum is presented with a cut-o¡ level 10-fold higher than that in (A), allowing only these strong peaks of the spectrum to be viewed.
C: The side chain part of a HSQC^TOCSY spectrum of the sample in (A) and (B). The 13 strong backbone cross peaks are the only ones re-
sulting in observable TOCSY cross peaks in the side chain region of the spectrum and can be assigned to, from top to bottom, 5 Glys, 1 Thr,
1 aromatic (Phe or His), 1 Glx, 2 Args, 1 Asp, 1 Ala and 1 Glx. These strong peaks correspond to the side chains of all, except two (Phe or
His, and Ser), of the last 15 residues of the C-terminus (-ATDRG EGGFG HSGRQ) of E. coli dUTPase.
FEBS 24694 9-3-01
J. Nord et al./FEBS Letters 432 (2001) 228^232 229
data suggests that a metal ion is bound to the C-terminal arm.
In a subsequent titration with dUDP, it was observed that
even though the resonances from the arm stayed essentially
una¡ected (Fig. 2A), signi¢cant changes in the chemical shifts
of some of the broader resonances were observed (data not
shown). These changes resulted in reasonable titration curves
(data not shown), corresponding to the presence of one bind-
ing site for dUDP in each E. coli dUTPase monomer, which is
in agreement with earlier observations (e.g. [12]). More im-
portant, however, is the observation that the arm in the E. coli
dUTPase is as £exible with a bound dUDP as without.
The active site inhibitor dUPNPP binds strongly to dUTP-
ase (Kd = 5U1036 M [12]). With the high concentration of
enzyme needed for NMR, the binding a⁄nity cannot be de-
termined. The e¡ect on the spectrum caused by the inhibitor
is, however, dramatic as can be seen from Fig. 2B. All the
sharp resonances from the arm are broadened upon inhibitor
binding and, furthermore, the broadening is substantial al-
ready after the addition of much less than one equivalent of
inhibitor, showing that the exchange rate of the inhibitor is in
the intermediate range on the NMR time scale (koff = 103 s31).
In the presence of excess of inhibitor, almost all resonances
from the arm are as broad as the other resonances, showing
that the arm is now essentially ¢xed (the correlation time of
the residues in the arm has increased to around 1037 s). This
shows that the third phosphate group (the Q-phosphate) in the
nucleoside triphosphate is essential for binding the arm as it is
for enzymic catalysis. We therefore suggest that the reason
that dUDP is not a substrate, even though the bond corre-
sponding to the cleavage site in dUTP is present, is due to its
inability to ¢x the arm. These observations are similar to what
was found previously by the use of CD [22]. In that study, a
shift in far-UV CD appeared only with dUPNPP, not with
dUDP, bound to the enzyme. The shift was dependent upon
the presence of Mg ions, but more importantly, it failed to
appear when the nucleoside triphosphate was mixed with
modi¢ed E. coli dUTPase, the C-terminal arm of which had
been removed. These ¢ndings support our conclusion that the
stronger peaks in the NMR spectra originate from amino acid
residues in the arm.
The present investigation shows that association with the
enzyme of nucleotides, also those that do not interact with the
C-terminal arm, can be followed using the NMR method.
When a detailed study of dUTPase by NMR has been con-
ducted, with a full assignment of the resonances of the protein
spectrum, chemical shifts induced by a nucleotide such as
dUDP (see above) would be possible to interpret in terms of
interactions of the nucleotide with speci¢c amino acid residues
in the active site of the enzyme.
In general, dUTPases of various origins show similarities in
catalytic properties, a ¢nding taken as an indication for a
common catalytic mechanism [27]. The two dUTPases most
thoroughly characterised in this regard, the ones from E. coli
and EIAV, di¡er, however, in one respect. For the EIAV
dUTPase, the binding of dUPNPP is not signi¢cantly a¡ected
by removal of the C-terminal arm [20], while in the E. coli
Fig. 2. 1H^15N HSQC spectra of E. coli dUTPase (1 mM active sites) with (A) the nucleotide dUDP added to a concentration of 4.4 mM, and
(B) the nucleotide dUPNPP present at a concentration of V1 mM. The cut-o¡ level is the same as in Fig. 1B, and thus set to show only peaks
of high amplitude. Note that the di¡erences between the spectrum in (A) of this ¢gure and the one in Fig. 1B (no nucleotide added) are very
small, while in (B) of this ¢gure the amplitudes of the resonances have decreased dramatically.
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enzyme, the binding strength becomes somewhat decreased
(by about one order of magnitude) [22]. These results were
obtained using di¡erent experimental methods and the pos-
sibility of artefacts cannot be excluded. A comparison of
the two enzymes in NMR properties was considered desir-
able.
A HSQC spectrum was acquired for the EIAV dUTPase
without nucleotide added (Fig. 3). There is a striking di¡er-
ence between this spectrum and the corresponding one for the
E. coli dUTPase shown in Fig. 1A,B. In the spectrum of
EIAV dUTPase, sharp signals were observed only for two
main chain amide groups. Therefore, it is clear that the arm
behaves di¡erently in the two proteins, even though X-ray
crystallography indicates that the arm is unordered in both
proteins. Kinetic data of nucleotide binding obtained earlier
by stopped-£ow measurements indicate that the movement of
the arm in the EIAV enzyme is fast compared with the dif-
fusion rate limited association of the nucleotide ligand [20].
Together with the NMR data, this would suggest that the rate
of movement of the arm in the EIAV dUTPase is in the Ws
time range, in contrast to the ns range observed for the C-
terminal residues in the bacterial enzyme. The slower speed of
the arm in the EIAV enzyme cannot per se be taken as an
indication of a reduction in the degrees of freedom relative to
the situation in the bacterial enzyme. The di¡erence between
the two enzymes may be trivial and primarily a question of
rate of movement of the arm. However, the similarity between
dUTPases in the behaviour and role of the arm assumed pre-
viously might need corroboration by further experiments.
A possible reason for the slower rate of movement of the
arm in the EIAV enzyme would be interactions of the arm
with the globular part of the enzyme, a situation that would
conceivably reduce the translational and rotational entropy of
the arm relative to the arm in the E. coli dUTPase. Another
possibility with a similar entropic outcome would be an inter-
nal structure of the arm present during movement. Such pos-
sibilities should be considered in the light of the di¡erences
between the two enzymes in C-terminal amino acid sequence.
The present investigation demonstrates NMR as a tool for
study of dUTPase. This is particularly valid for dUTPases
with a highly £exible C-terminal arm, e.g. E. coli dUTPase.
The £exibility suggested by previous investigators has been
given a more precise and quantitative nature. The methods
for over-expression and puri¢cation recently adapted for
dUTPases in our laboratory [8,24] have proven to be suitable
for preparation of isotope labelled proteins. The results sug-
gest that future use of the NMR technique for investigations
of dUTPase should be rewarding.
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Fig. 3. A 1H^15N HSQC spectrum of EIAV dUTPase (1 mM active sites) presented, as for E. coli dUTPase in Fig. 1A,B, with (A) a low cut-
o¡ level that shows all the peaks of the spectrum and (B) with a cut-o¡ level 10-fold higher (as in Fig. 1B) allowing only resonances of high
amplitude to be displayed. Note the lack of £exibility in this enzyme in contrast to the £exibility indicated by the corresponding spectrum of
the E. coli dUTPase (Fig. 1B).
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